Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan vs Ramipril on Renal Endothelial Dysfunction in Hypertensive T2D
NCT00240422Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Feb 2003
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 4 trial of telmisartan in hypertension (HTN), type 2 diabetes mellitus (T2DM), sponsored by Boehringer Ingelheim. Started Feb 2003; status: completed.
02
Drugs
telmisartan
03
Conditions
hypertension (HTN)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00240422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00240422.